Financings Of The Fortnight Presents A Mid-Year Overview Of Early-Stage Biotech Financings
This article was originally published in The Pink Sheet Daily
Executive Summary
Plus news on recent financings by Nimbus Discovery, Redwood Biosciences, Zafgen and Clovis Oncology.
You may also be interested in...
Financings Of The Fortnight Tries To Beat The Summer Heat
Plus updates on Essence Group, Coronado Biosciences, Merrimack Pharmaceuticals and SARcode Biosciences
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.